Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Genedx Holdings
ISIN US81663L2007
|WKN A3EEXG
Market cap (in EUR)
1,657 m
Country
United States
Sector
Healthcare
Overview
Description
GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 1,657 m |
| EPS, EUR | -0.66 |
| P/B ratio | 6.3 |
| P/E ratio | 1,444.1 |
| Dividend yield | - |
Income statement (2025)
| Revenue, EUR | 379 m |
| Net income, EUR | -19 m |
| Profit margin | -4.92% |
What ETF is Genedx Holdings in?
There are 2 ETFs which contain Genedx Holdings. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genedx Holdings is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Amundi MSCI Disruptive Technology UCITS ETF Acc | 0.01% | Equity World Technology Social/Environmental Innovation | 139 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.02% | Equity United States Small Cap | 204 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.